Skip to content

Assessment of add on effect of Kimshukatvagadi ghana capsule in Diabetes

A DOUBLE BLIND RANDOMISED PLACEBO CONTROLLED EVALUATATION OF ADJUVANT EFFECT OF KIMSHUKATVAGADI GHANA CAPSULE IN PRAMEHA WITH SPECIAL REFRENCE TO DIABETES MELLITUS TYPE II

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/023027
Enrollment
62
Registered
2020-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: KIMSHUKATVAGADI GHANA CAPSULE 1 GRAM THREE TIMES A DAY WITH BUTTERMILK AFTER FOOD FOR 12 WEEKS: Kimshukatvagadi ghana capsule is an ayurvedic medicine having reference in Sahasrayoga by

Sponsors

Dean Faculty of Ayurved Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Known cases of Diabetes Mellitus Type II and on medication showing symptoms of Prameha. 2) Patients with FBS 125mg/dl to 300 mg/dl and PPBS 140 mg/dl to 400 mg/dl (both inclusive) 3) Patients with HbA1C levels between 7.0 - 9.5 mg%

Exclusion criteria

Exclusion criteria: 1) Patients having FBS more than 300mg/dl PP2BS more than 400mg/dl HbA1C more than 9.5mg% 2) Patients showing acute complications and chronic complications - neuropathy, nephropathy, retinopathy. 3) Patients with Diabetes Mellitus Type I 4) Lactating and Pregnant Women 5) Patients with other systemic diseases - IHD, uncontrolled hypertension.

Design outcomes

Primary

MeasureTime frame
Effect on FBS, PP2BS and HbA1CTimepoint: Effect on FBS and PP2BS at baseline and after every 4 weeks till 12 weeks. Effect on HbA1C at baseline and at the end of 12 weeks

Secondary

MeasureTime frame
Effect on symptoms of Prameha-Weakness (Daurbalya),Polyphagia(Kshudha vriddhi),Polydypsia (Pipasa vriddhi),Polyuria with turbidity in urine (Prabhuta Aavila Mutrata), Nocturnal micturition (Nakta Mutrata),Cramps (Pindikodvestana),Excess sweating(swedapravritti), Dyspnoea on exertion (Shwasakastata) Timepoint: Effect on symptoms at baseline and at the end of every 2 weeks till 12 weeks.

Countries

India

Contacts

Public ContactDr Garima Singh

Parul Institute of Ayurved

garimasingh2794@gmail.com7016977164

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026